Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/GLOBAL-BLOOD-THERAPEUTICS-23320379/nieuws/Inclacumab-en-GBT601-van-Global-Blood-Therapeutics-Inc-krijgen-van-de-Amerikaanse-FDA-de-status-va-40660235/?utm_source=whatsapp&utm_medium=social&utm_campaign=share